RESUMEN
PURPOSE: The incidence of primary congenital hypothyroidism (CH) has grown progressively and literature data indicate an association between CH and congenital malformations. The purpose of this study is to establish the current incidence of CH in the Italian Region of Piedmont and verify the relationship between CH diagnostic categories and associated malformations. METHODS: The biochemical and clinical data of 105 newborns with CH diagnosed in the period January 2014 to December 2019 were analyzed. RESULTS: The incidence of CH in the Italian Piedmont region in the 2014-2019 period increased to 1:1090. Thyroid dysgenesis was responsible for 47.6% (50/105) of all cases, with agenesis in 14.3% (15/105), while ectopia and hypoplasia in 23.8% (25/105) and 9.5% (10/105) of the cases, respectively; dyshormonogenesis defects were found in 52.4% (55/105) of cases. Congenital extra-thyroid anomalies were identified in 33/105 (31.4%) of newborns with CH and mainly involve the cardiac system (17/85, 16.1%), urogenital tract (7/85, 6.7%), gastrointestinal tract (5/105, 4.8%), and the musculoskeletal system (5/105, 4.8%). The highest rate of malformations was observed in patients with thyroid agenesis and dyshormonogenesis, respectively, in 53.5% and 36.4% of cases, while in the presence of thyroid ectopia and hypoplasia, the rate was 12% and 20%, respectively, (p = 0.03). CONCLUSION: In the Italian region of Piedmont, the incidence of primary CH has been increased over time, with a variation in the percentage of the different forms of CH. Congenital malformations, especially affecting the cardiovascular, urogenital, gastrointestinal, and musculoskeletal systems, seem to be mainly associated with thyroid agenesis or defects in hormonogenesis.
Asunto(s)
Hipotiroidismo Congénito , Disgenesias Tiroideas , Hipotiroidismo Congénito/diagnóstico , Hipotiroidismo Congénito/epidemiología , Humanos , Incidencia , Recién Nacido , Italia/epidemiología , Tamizaje Neonatal , Disgenesias Tiroideas/epidemiologíaRESUMEN
Background: The etiology of most cases of congenital hypothyroidism (CHT) due to thyroid dysgenesis (DG) is unknown. If transient environmental factors can impact on thyroid gland development, then clustering of cases in time and/or space may occur, and this would be more likely in thyroid DG than dyshormonogenesis (DHG). Methods: The newborn screening program for CHT in Scotland is linked to a central database that includes case details such as postcode. The etiology of CHT is investigated in many cases of CHT using scintigraphy and/or ultrasonography. We looked for evidence of a change in CHT incidence with year of birth and according to season of the year. We then undertook space-time clustering analysis (using a method based on K-functions, with nearest neighbor thresholds) of CHT in Scotland between 1979 and 2015. We also looked for evidence of overall changes associated with sex and area-based birth density. Results: Of 531 cases with CHT during the study period, 290 cases had been categorized as DG (n = 229) or DHG (n = 61) following more detailed investigation. The incidence of CHT increased with year of birth and was in part linked to changing methodology, but there was no seasonality. There was no evidence of overall space-time clustering (p = 0.06), but there was evidence of clustering in babies with DG (p = 0.007). This picture appeared to be most closely linked to underlying thyroid gland hypoplasia rather than thyroid gland agenesis or ectopia. There was significant space-time clustering for both males and females, but clustering was restricted to lesser birth density areas. There was also evidence of clustering for unknown cases (p < 0.001). Clustering of these cases was restricted to females but was present for cases from both greater and lesser birth density areas. There was no evidence of clustering in cases of DHG. Conclusions: These data suggest that an unidentified environmental factor or factors may be involved in the etiology of thyroid DG in Scotland. The variation in CHT incidence observed internationally may reflect environmental as well as genetic factors.
Asunto(s)
Hipotiroidismo Congénito/epidemiología , Exposición a Riesgos Ambientales/estadística & datos numéricos , Disgenesias Tiroideas/epidemiología , Hipotiroidismo Congénito/diagnóstico , Femenino , Humanos , Incidencia , Recién Nacido , Masculino , Tamizaje Neonatal , Cintigrafía , Factores de Riesgo , Escocia/epidemiología , Agrupamiento Espacio-Temporal , Disgenesias Tiroideas/diagnóstico , UltrasonografíaRESUMEN
Objectives We evaluated the spectrum of diseases accompanying congenital hypothyroidism (CH) in the United Arab Emirates and compared them with internationally studied patterns. Methods The presented retrospective cross-sectional study took place in two government tertiary care centres. In total, 204 patients with a confirmed diagnosis of CH and a minimum period of follow-up of 1 year were included. Patients with Down syndrome, infants born at <35 weeks of gestation, and babies with TORCH (Toxoplasma gondii, Other viruses [HIV, measles, etc.], Rubella, Cytomegalovirus, and Herpes simplex) infections were subsequently excluded from the study. Results Of the subjects with CH, 39% had associated extrathyroidal anomalies (ETAs); among these, 25% had a single anomaly. A significant proportion of Arab males were affected by CH as compared to other ethnic groups. Dyshormonogenesis was the commonest aetiological cause (55%) of CH. Males with an ectopic lingual thyroid gland had significant ETAs as compared to females of the same cohort. The most common ETAs were congenital heart disease (16%), followed by urogenital tract anomalies (14%). Conclusions Detection of a high rate and variability of ETAs associated with CH necessitates the formulation of a structured screening programme including appropriate clinical, laboratory, and imaging tools to detect ETAs at an earlier stage.
Asunto(s)
Hipotiroidismo Congénito/fisiopatología , Cardiopatías Congénitas/epidemiología , Disgenesias Tiroideas/epidemiología , Anomalías Urogenitales/epidemiología , Adolescente , Biomarcadores/análisis , Niño , Preescolar , Estudios Transversales , Femenino , Estudios de Seguimiento , Cardiopatías Congénitas/patología , Humanos , Lactante , Recién Nacido , Masculino , Pronóstico , Estudios Retrospectivos , Disgenesias Tiroideas/patología , Emiratos Árabes Unidos/epidemiologíaRESUMEN
Neonatal screening in Macedonia detects congenital hypothyroidism (CH) with an incidence of 1 in 1,585, and more than 50% of cases exhibit a normally located gland-in-situ (GIS). Monogenic mutations causing dyshormonogenesis may underlie GIS CH; additionally, a small proportion of thyroid hypoplasia has a monogenic cause, such as TSHR and PAX8 defects. The genetic architecture of Macedonian CH cases has not previously been studied. We recruited screening-detected, non-syndromic GIS CH or thyroid hypoplasia cases (n = 40) exhibiting a spectrum of biochemical thyroid dysfunction ranging from severe permanent to mild transient CH and including 11 familial cases. Cases were born at term, with birth weight >3,000 g, and thyroid morphologies included goiter (n = 11), thyroid hypoplasia (n = 6), and apparently normal-sized thyroid. A comprehensive, phenotype-driven, Sanger sequencing approach was used to identify genetic mutations underlying CH, by sequentially screening known dyshormonogenesis-associated genes and TSHR in GIS cases and TSHR and PAX8 in cases with thyroid hypoplasia. Potentially pathogenic variants were identified in 14 cases, of which four were definitively causative; we also detected digenic variants in three cases. Seventeen variants (nine novel) were identified in TPO (n = 4), TG (n = 3), TSHR (n = 4), DUOX2 (n = 4), and PAX8 (n = 2). No mutations were detected in DUOXA2, NIS, IYD, and SLC26A7. The relatively low mutation frequency suggests that factors other than recognized monogenic causes (oligogenic variants, environmental factors, or novel genes) may contribute to GIS CH in this region. Future non-hypothesis-driven, next-generation sequencing studies are required to confirm these findings.
Asunto(s)
Hipotiroidismo Congénito/diagnóstico , Mutación , Factor de Transcripción PAX8/genética , Receptores de Tirotropina/genética , Disgenesias Tiroideas/diagnóstico , Niño , Preescolar , Hipotiroidismo Congénito/epidemiología , Hipotiroidismo Congénito/genética , Secuenciación de Nucleótidos de Alto Rendimiento , Humanos , Lactante , Recién Nacido , Fenotipo , República de Macedonia del Norte/epidemiología , Disgenesias Tiroideas/epidemiología , Disgenesias Tiroideas/genéticaRESUMEN
Background: Thyroid dysgenesis (TD), which is caused by gland developmental abnormalities, is the most common cause of congenital hypothyroidism (CH). In addition, advances in diagnostic techniques have facilitated the identification of mild CH patients with a gland-in-situ (GIS) with normal thyroid morphology. Therefore, TD and GIS account for the vast majority of CH cases. Methods: Sixteen known genes to be related to CH were sequenced and screened for variations by next-generation sequencing (NGS) in a cohort of 377 CH cases, including 288 TD cases and 89 GIS cases. Results: In our CH cohort, we found that DUOX2 (21.22%) was the most commonly variant pathogenic gene, while DUOXA2 was prominent in TD (18.75%) and DUOX2 was prominent in GIS (34.83%). Both biallelic and triple variants of DUOX2 were found to be most common in children with TD and children with GIS. The most frequent combination was DUOX2 with DUOXA1 among the 61 patients who carried digenic variants. We also found for the first time that biallelic TG, DUOXA2, and DUOXA1 variants participate in the pathogenesis of TD. In addition, the variant p.Y246X in DUOXA2 was the most common variant hotspot, with 58 novel variants identified in our study. Conclusion: We meticulously described the types and characteristics of variants from sixteen known gene in children with TD and GIS in the Chinese population, suggesting that DUOXA2 and DUOX2 variants may confer susceptibility to TD and GIS via polygenic inheritance and multiple factors, which further expands the genotype-phenotype spectrum of CH in China.
Asunto(s)
Hipotiroidismo Congénito/patología , Oxidasas Duales/genética , Predisposición Genética a la Enfermedad , Proteínas de la Membrana/genética , Mutación , Disgenesias Tiroideas/patología , Niño , China/epidemiología , Estudios de Cohortes , Hipotiroidismo Congénito/epidemiología , Hipotiroidismo Congénito/genética , Secuenciación de Nucleótidos de Alto Rendimiento , Humanos , Fenotipo , Pronóstico , Disgenesias Tiroideas/epidemiología , Disgenesias Tiroideas/genéticaRESUMEN
Context: Thyroid hemiagenesis (THA) constitutes a rare, congenital disorder that is characterized by an absence of one thyroid lobe. Because the pathogenesis and clinical significance of this malformation remain undefined, specific clinical recommendations are lacking, especially for asymptomatic cases. Evidence Acquisition: The PubMed database was searched (years 1970 to 2017), and the following terms were used to retrieve the results: "thyroid hemiagenesis," "thyroid hemiaplasia," "one thyroid lobe agenesis," and "one thyroid lobe aplasia." Subsequently, reference sections of the retrieved articles were searched. Evidence Synthesis: There is a noticeable susceptibility of subjects with THA to develop additional thyroid and nonthyroidal pathologies. In pathogenesis of concomitant thyroid pathologies, a chronic elevation in thyroid-stimulating hormone values may play an important role. Thus far, genetic studies failed to find a common genetic background of the anomaly, and the potential underlying cause was identified in a minority of the cases. Conclusions: Patients with THA are prone to develop additional thyroid pathologies and theoretically might benefit from l-thyroxine treatment to lower the thyrotropin levels to those observed in the normal population. However, further research should be done to ascertain whether such intervention early in life would prevent development of associated thyroid conditions. At least, increased vigilance should be maintained to reveal all of the concomitant disorders as soon as possible during follow-up examinations. Application of high-throughput technologies enabling a genome-wide search for novel factors involved in thyroid embryogenesis might be the next step to expand the knowledge on THA pathogenesis.
Asunto(s)
Antecedentes Genéticos , Predisposición Genética a la Enfermedad/epidemiología , Disgenesias Tiroideas/epidemiología , Disgenesias Tiroideas/patología , Animales , Proteínas de Unión al ADN/genética , Femenino , Humanos , Incidencia , Masculino , Ratones , Mutación , Factor de Transcripción PAX8/genética , Pronóstico , Complejo de la Endopetidasa Proteasomal/genética , Enfermedades Raras , Medición de Riesgo , Índice de Severidad de la Enfermedad , Disgenesias Tiroideas/diagnóstico por imagen , Disgenesias Tiroideas/tratamiento farmacológico , Pruebas de Función de la Tiroides , Neoplasias de la Tiroides/genética , Neoplasias de la Tiroides/patología , Tiroxina/uso terapéutico , Factores de Transcripción , Ultrasonografía Doppler/métodosRESUMEN
BACKGROUND: Thyroid hemiagenesis is a rare congenital variant characterized by the lack of development of one thyroid lobe with no clinical manifestations. METHODS: This study was performed to determine the prevalence and characteristics of thyroid hemiagenesis in a normal Japanese population. This cross-sectional study was performed from October 9, 2011, to April 30, 2015. In total, 299,908 children and young adults in the Fukushima Health Management Survey were examined to determine the presence of thyroid agenesis or hemiagenesis. Thyroid width, thickness, and length were measured in 292,452 of these subjects. RESULTS: Thyroid agenesis was diagnosed in 13 subjects, and hemiagenesis was detected in 67 subjects (0.02%; 22.3/100,000 individuals). Although there was no significant sex-related difference (p = 0.067), the female:male ratio was 1.67:1.00. Females were significantly dominant in right hemiagenesis, while there was no difference in left hemiagenesis between males and females. The thyroid volumes at the 2.5th and 97.5th percentiles for age and body surface area were determined for each sex. Multivariate regression analysis showed that a large hemithyroid volume was independently associated with the presence of contralateral hemiagenesis (p < 0.001). CONCLUSION: The prevalence of thyroid hemiagenesis in the present study is in agreement with that reported in other countries. The prevalence of right hemiagenesis was higher in females, and the larger contralateral lobe in patients with rather than without hemiagenesis may have been caused by a compensatory feedback mechanism to prevent hypothyroidism. In addition, the prevalence of hemiagenesis, especially right hemiagenesis, may be affected by sex-related factors similar to those in patients with an ectopic thyroid gland.
Asunto(s)
Anomalías Inducidas por Radiación/etiología , Accidente Nuclear de Fukushima , Disgenesias Tiroideas/etiología , Glándula Tiroides/efectos de la radiación , Anomalías Inducidas por Radiación/diagnóstico por imagen , Anomalías Inducidas por Radiación/epidemiología , Anomalías Inducidas por Radiación/fisiopatología , Adolescente , Adulto , Niño , Preescolar , Estudios de Cohortes , Estudios Transversales , Femenino , Encuestas Epidemiológicas , Humanos , Lactante , Japón/epidemiología , Masculino , Tamizaje Masivo , Tamaño de los Órganos/efectos de la radiación , Prevalencia , Índice de Severidad de la Enfermedad , Factores Sexuales , Disgenesias Tiroideas/diagnóstico por imagen , Disgenesias Tiroideas/epidemiología , Disgenesias Tiroideas/fisiopatología , Glándula Tiroides/diagnóstico por imagen , Glándula Tiroides/patología , Glándula Tiroides/fisiopatología , Ultrasonografía , Adulto JovenRESUMEN
Developmental anomalies of the thyroid gland, defined as thyroid dysgenesis, underlie the majority of cases of congenital hypothyroidism. Thyroid dysgenesis is predominantly a sporadic disorder although a reported familial enrichment, variation of incidence by ethnicity and the monogenic defects associated mainly with athyreosis or orthotopic thyroid hypoplasia, suggest a genetic contribution. Of note, the most common developmental anomaly, thyroid ectopy, remains unexplained. Ectopy may result from multiple genetic or epigenetic variants in the germline and/or at the somatic level. This review provides a brief overview of the monogenic defects in candidate genes that have been identified so far and of the syndromes which are known to be associated with thyroid dysgenesis.
Asunto(s)
Morfogénesis/fisiología , Disgenesias Tiroideas/genética , Glándula Tiroides/embriología , Animales , Hipotiroidismo Congénito/epidemiología , Hipotiroidismo Congénito/genética , Femenino , Estudios de Asociación Genética , Humanos , Hipotiroidismo/epidemiología , Hipotiroidismo/etiología , Incidencia , Masculino , Enfermedades de la Tiroides/complicaciones , Enfermedades de la Tiroides/epidemiología , Enfermedades de la Tiroides/genética , Disgenesias Tiroideas/embriología , Disgenesias Tiroideas/epidemiología , Glándula Tiroides/anomalías , Glándula Tiroides/crecimiento & desarrolloRESUMEN
Ectopy is the most common embryogenetic defect of the thyroid gland, representing between 48 and 61% of all thyroid dysgeneses. Persistence of thyroid tissue in the context of a thyroglossal duct remnant and lingual thyroid tissue are the most common defects. Although most cases of ectopic thyroid are asymptomatic, any disease affecting the thyroid may potentially involve the ectopic tissue, including malignancies. The prevalence of differentiated thyroid carcinoma in lingual thyroid and thyroglossal duct cyst is around 1% of patients affected with the above thyroid ectopies. We here review the current literature concerning primary thyroid carcinomas originating from thyroid tissue on thyroglossal duct cysts and lingual thyroid.
Asunto(s)
Adenocarcinoma Folicular/epidemiología , Carcinoma Papilar/epidemiología , Coristoma/epidemiología , Quiste Tirogloso/epidemiología , Disgenesias Tiroideas/epidemiología , Neoplasias de la Tiroides/epidemiología , Adenocarcinoma Folicular/diagnóstico , Adenocarcinoma Folicular/cirugía , Carcinoma Papilar/diagnóstico , Carcinoma Papilar/cirugía , Comorbilidad , Susceptibilidad a Enfermedades , Humanos , Tiroides Lingual/epidemiología , Prevalencia , Glándula Tiroides/embriología , Neoplasias de la Tiroides/diagnóstico , Neoplasias de la Tiroides/cirugía , TiroidectomíaRESUMEN
Objective Ectopic thyroid tissue (ETT) is a rare abnormality of the thyroid gland and the true prevalence and importance is not known. The aim of this study was to evaluate ultrasonography (US) guided fine needle aspiration biposy (FNAB) results, sonographic features, and frequency of ETT detected in the midline of the neck. Subjects and methods Five thousand five hundred and twenty outpatients who were referred to our thyroid clinic between September 2010 and April 2012 and underwent thyroid US, were retrospectively analyzed. Patients with ETT, detected in the midline of the neck in US were included in the study. Thyroid functions, sonographic features, and US guided FNAB results were evaluated. Results There were 81 (81.8%) female and 18 (18.2%) male patients with a mean age of 50.9 ± 11.7. The ETT in the midline was present in 1.79% (99/5,520) of the patients. In the majority of the patients, benign sonographic features (isoechoic, regular margin, type 1 vascularization) were detected. There were 92 (92.9%) patients with a previous history of thyroidectomy and all were histopathologically benign. In 7 (7.1%) patients, there was no history of thyroid operation. FNAB results of ETT were benign. Conclusion This study evaluated the importance of ETT detected incidentally in the midline of the neck. Especially in patients with a history of thyroidectomy, the thyroid masses in the midline of the neck can be found as incidental with imaging methods. Our results suggests that the incidence of malignancy in this group is much lower than orthotopic thyroid nodules and they are often benign.
Asunto(s)
Humanos , Masculino , Femenino , Adulto , Persona de Mediana Edad , Coristoma/patología , Disgenesias Tiroideas/patología , Biopsia por Aspiración con Aguja Fina Guiada por Ultrasonido Endoscópico , Cuello/patología , Glándula Tiroides/patología , Glándula Tiroides/diagnóstico por imagen , Turquía/epidemiología , Cintigrafía , Prevalencia , Estudios Retrospectivos , Coristoma/epidemiología , Hallazgos Incidentales , Disgenesias Tiroideas/epidemiología , Disgenesias Tiroideas/diagnóstico por imagen , Puntos Anatómicos de Referencia/diagnóstico por imagen , Cuello/diagnóstico por imagenRESUMEN
Thyroid hemiagenesis (TH) is a rare congenital abnormality of the thyroid gland, characterised by the absence of one lobe. The true prevalence of this congenital abnormality is not known because the absence of one thyroid lobe usually does not cause clinical symptoms by itself. Between 1970 and 2010, 329 cases of TH have been reported. It is interesting to note that most cases have an agenesis of the left lobe (80% of cases) followed by the isthmus (44-50% of cases). Although the female to male ratio was 1:1.4 in 24,032 unselected 11-to 14-yr-old schoolchildren from South-eastern Sicily, several other reports have documented a higher prevalence in women, which may indicate a possible gender association. Most cases of TH are diagnosed when patients present a lesion in the functioning lobe. The functioning lobe of the thyroid gland can be a site of pathological changes similar to a normally developed gland and may present a spectrum of diseases like multinodular goiter, colloid goiter, follicular adenoma, thyroiditis, hypothyroidism and hyperthyroidism. In three of our patients, TH was associated with Hashimoto thyroiditis (n = 1) and with subclinical hypothyroidism (n = 2). The frequency of thyroid abnormalities in patients with TH varies with age, due to the longer exposure of the hemi-agenetic gland to TSH overstimulation in older patients. This could explain the controversy about the benign character of this anomaly. Other extrathyroidal lesions, such as parathyroid adenoma or hyperplasia, cervical thymic cysts, ectopic sublingual thyroid gland and thyroglossal duct cyst have been reported with TH. Therefore, systematic follow-up of all identified cases is recommended.
Asunto(s)
Envejecimiento/fisiología , Disgenesias Tiroideas , Adolescente , Adulto , Niño , Femenino , Humanos , Masculino , Estudios Retrospectivos , Disgenesias Tiroideas/diagnóstico , Disgenesias Tiroideas/epidemiología , Disgenesias Tiroideas/genética , Disgenesias Tiroideas/terapia , Glándula Tiroides/embriología , Glándula Tiroides/crecimiento & desarrolloRESUMEN
CONTEXT: Congenital hypothyroidism (CH) may arise from dual foci thyroid ectopia. OBJECTIVE: To ascertain the incidence of dual ectopia in CH and compare the phenotype to single ectopia or thyroid agenesis. DESIGN AND SETTING: Single center, retrospective study of babies referred through UK Newborn Bloodspot Screening between 2006 and 2012. PATIENTS: A total of 837 377 babies were screened for CH, with 730 referred for diagnostic confirmation (134 thyroid ectopia, 73 thyroid agenesis). INTERVENTION: Thyroid isotope scans were classified as single or dual ectopia. Biochemical, clinical, and sociodemographic data were collected. MAIN OUTCOME MEASURES: The incidence of thyroid dual ectopia and comparison of clinical parameters with single ectopia and agenesis. RESULTS: Thyroid ectopia occurs with an incidence of 16 per 100 000 births. Twenty-one of 134 (15.7%) babies with thyroid ectopia had dual foci, an incidence of 2.5 per 100 000 births. Dual ectopia infants had lower mean bloodspot TSH compared to single ectopia and agenesis groups (P < .001). On venous sampling, the ectopia group differences were absent, but the difference with the agenesis group remained (TSH, P < .001; free T4, P < .001). There were no between-group differences for gestation, ethnicity, maternal age, or levothyroxine requirements at 12 months. CONCLUSIONS: Thyroid dual ectopia has an incidence of 2.5 per 100 000 births. Early functional activity in the ectopia groups with detectable serum free T4 concentrations is lost at 12 months when T4 requirements are the same as the agenesis group.
Asunto(s)
Hipotiroidismo Congénito/diagnóstico , Disgenesias Tiroideas/epidemiología , Glándula Tiroides/anomalías , Hipotiroidismo Congénito/sangre , Femenino , Humanos , Incidencia , Lactante , Recién Nacido , Masculino , Tamizaje Neonatal , Estudios Retrospectivos , Pruebas de Función de la Tiroides , Tirotropina/sangre , Tiroxina/sangreRESUMEN
INTRODUÇÃO: Hipotireoidismo Congênito (HC), é uma das doenças metabólicas mais comuns na infância com incidência de 1:3.000 a 1:4.000 recém-nascidos. Um grupo de doenças relacionadas às alterações no desenvolvimento da tireoide, denominadas disgenesias tireoidianas (DT), responsabiliza-se por aproximadamente 85% de todos os casos de HC, sendo sua patogênese pouco conhecida. OBJETIVOS: Geral: Caracterização clínica e genética de pacientes com HC diagnosticados com disgenesia tireoidiana. Específicos: 1. Caracterizar clínica dos indivíduos com HC em acompanhamento na APAE/Salvador (Associação de Pais e Amigos dos Excepcionais); 2. Avaliar a existência de associação entre malformações tireoidianas e malformações cardiacos; 3. Pesquisar polimorfismos e mutações nos genes candidatos: PAX8, TSH-R, NKX2.5 e HES1, em pacientes diagnosticados com disgenesia tireoidiana; 4. Pesquisar o gene TSH-R numa coorte de pacientes com HC diagnosticados no programa de triagem neonatal da França. METODOLOGIA: Até o ano de 2016, 1.188 crianças foram diagnosticadas com HC e 773 estão em acompanhamento. Duzentos e dezoito crianças confirmadas com HC foram caracterizadas clinicamente através de testes de função da tireoide (TT4 e TSH), ultrassonografia e cintilografia, seguidas de dosagem de tireoglobulina. Toda a região codificantes dos genes PAX8, TSH-R, NKX2.5 e HES1 incluindo íntrons e éxons foram amplificados a partir do DNA genômico através da PCR (Reação em cadeia da Polimerase) utilizando-se técnicas padrão seguida de Sequenciamento direto. RESULTADOS: Sessenta e três pacientes foram diagnosticados com DT e 155 com glândula tópica normal. Hipoplasia representou 33,4% dos casos de DT, agenesia 19%, ectopia 27% e hemiagenesia 20,6%. Altos concentrações de TSH no teste do pezinho foram detectados no grupo das agenesias seguido das hipoplasias. Na análise genética/molecular, 31 (49,2%) dos pacientes foram identificados com o polimorfismo p.D727E em heterozigose e 4 (6,4%) em homozigose, no gene TSH-R; 4/63 pacientes tiveram o polimorfismo p.P52T em heterozigose; 14/63 apresentaram a variante polimórfica p.N181N e 2/63 apresentaram a substituição sinônima conhecida p.L645L, todos no gene TSH-R. o polimorfismo p.Glu21 foi encontrado em 54% dos pacientes e p.Gln181 encontrado em 1 paciente no gene NKX2.5. Nenhuma alteração foi encontrada no gene HES1, bem como em PAX8. CONCLUSÕES: Este é o primeiro estudo realizado na população de HC no Estado da Bahia. Análises clínicas revelaram um padrão distinto entre os subgrupos da DT quando comparados com glândula normal; 6 polimorfismos já descritos foram encontrados em dois genes candidatos. Nenhuma mutação patogênica foi encontrada. A descrição fenotípica é essencial para a correta avaliação genética e os mecanismos nela implicados, além de utilizados para predição da gravidade do HC. A identificação de novos genes ou eventos moleculares que controlam a função tireoidiana pós-natal seria de grande utilidade no esclarecimento das DT
INTRODUCTION: Congenital hypothyroidism (CH), is the most common metabolic diseases in childhood with incidence of 1: 3000-1: 4000 newborns. A group of diseases related to alterations in the development of the thyroid, called thyroid dysgenesis (TD), is responsible for approximated 85% of all HC cases, and the majority has unknown pathogenesis. OBJECTIVES: General: clinical and genetic characterization of CH patients diagnosed with TD. Specific: 1. CH clinical characterization in individuals followed at APAE/Salvador; 2. evaluating the association between thyroid abnormalities and other abnormalities or syndromes; 3. search polymorphisms and mutations in known candidate genes for TD: PAX8, TSH-R, NKX2.5 and HES1; 4. XX METHODS: Until the year 2016, 1.188 children were diagnosed for CH and 773 were actually follow in APAE-Salvador. A continuous series of 218 children with confirmed HC were characterized clinically through thyroid function tests (TT4 and TSH), thyroid ultrasound and scintigraphy, followed by serum thyroglobulin measurement. The entire coding region of the candidate genes (PAX8, TSH-R, NKX2.5 and HES1), including exon/intron boundaries, was amplified from genomic DNA by polymerase chain reaction (PCR) using standard techniques, followed by direct sequencing. Results: Sixty-three patients were diagnosed with DT and 155 with in situ thyroid gland (ISTG). Hypoplasia represented 33,4% of all cases of DT, agenesis (19%), ectopy (27%) and hemiagenesis (20,6%). The higher screening TSH levels was in the agenetic group followed by hypoplasia. In the genetic/molecular analysis, 31 (49,2%) patients were identified with a polymorphism of TSH-R gene (p.D727E); 4/63 patients had a heterozygous p.P52T; 14/63 patients showed p.N187N polymorphic variants of the gene; and 2/63 patients presented a known p.L645L synonimous substitution. The polymorphism p.Glu21was found in 54% of patients, and p.Gln181 found in only one patient in the NKX2.5 gene. None alteration was detected in HES1 gene. CONCLUSIONS: This is the first CH population-based study in State of Bahia, Brazil. Clinical analysis revealed distinct hormonal patterns in DT subgroup when compared with ISTG, with only 6 known polymorphisms identified in few cases of TD in TSH-R, PAX8, NKX2.5 and HES1 genes. No mutation was found in a candidate genes studied. A detailed description of phenotype might be essential to target the correct genetic and mechanism implicated, and useful to predict CH severity. The identification of additional genes or molecular events controlling early postnatal thyroid function would be helpful.
Asunto(s)
Humanos , Disgenesias Tiroideas/diagnóstico , Disgenesias Tiroideas/epidemiología , Disgenesias Tiroideas/inmunología , Disgenesias Tiroideas/patología , Disgenesias Tiroideas/prevención & control , Disgenesias Tiroideas/psicología , Disgenesias Tiroideas/rehabilitaciónRESUMEN
OBJECTIVE: Ectopic thyroid tissue (ETT) is a rare abnormality of the thyroid gland and the true prevalence and importance is not known. The aim of this study was to evaluate ultrasonography (US) guided fine needle aspiration biposy (FNAB) results, sonographic features, and frequency of ETT detected in the midline of the neck. SUBJECTS AND METHODS: Five thousand five hundred and twenty outpatients who were referred to our thyroid clinic between September 2010 and April 2012 and underwent thyroid US, were retrospectively analyzed. Patients with ETT, detected in the midline of the neck in US were included in the study. Thyroid functions, sonographic features, and US guided FNAB results were evaluated. RESULTS: There were 81 (81.8%) female and 18 (18.2%) male patients with a mean age of 50.9 ± 11.7. The ETT in the midline was present in 1.79% (99/5,520) of the patients. In the majority of the patients, benign sonographic features (isoechoic, regular margin, type 1 vascularization) were detected. There were 92 (92.9%) patients with a previous history of thyroidectomy and all were histopathologically benign. In 7 (7.1%) patients, there was no history of thyroid operation. FNAB results of ETT were benign. CONCLUSION: This study evaluated the importance of ETT detected incidentally in the midline of the neck. Especially in patients with a history of thyroidectomy, the thyroid masses in the midline of the neck can be found as incidental with imaging methods. Our results suggests that the incidence of malignancy in this group is much lower than orthotopic thyroid nodules and they are often benign.
Asunto(s)
Coristoma/patología , Biopsia por Aspiración con Aguja Fina Guiada por Ultrasonido Endoscópico , Cuello/patología , Disgenesias Tiroideas/patología , Adulto , Puntos Anatómicos de Referencia/diagnóstico por imagen , Coristoma/epidemiología , Femenino , Humanos , Hallazgos Incidentales , Masculino , Persona de Mediana Edad , Cuello/diagnóstico por imagen , Prevalencia , Cintigrafía , Estudios Retrospectivos , Disgenesias Tiroideas/diagnóstico por imagen , Disgenesias Tiroideas/epidemiología , Glándula Tiroides/diagnóstico por imagen , Glándula Tiroides/patología , Turquía/epidemiologíaRESUMEN
OBJECTIVE: Thyroid hemiagenesis is a rare congenital disorder characterized by the absence of a lobe and/or of isthmus. Studies on the association between thyroid hemiagenesis, Graves' disease and differentiated thyroid cancer are rare. CASE PRESENTATION: We describe the medical and surgical history of a patient in whom a molecular evaluation was performed. A 36-year-old man presented with symptoms and signs of hyperthyroidism of a few months' duration. Hyperthyroidism was confirmed biochemically and anti-TSH-receptor antibodies were positive. Thyroid ultrasonography showed no left lobe and demonstrated a diffused enlargement of the right lobe; an ipoechoic, non-homogenous nodule 15 millimeters in size was identified in the middle part of the lobe. A 99mTc-pertechnetate thyroid scintigraphy (111 MBq) confirmed thyroid hemiagenesis due to the absence of the left lobe. Treatment with methimazole (30 mg/day) was started. As the patient's hyperthyroidism improved, he underwent fine-needle needle aspiration cytology (FNAC) of the right nodule. Cytology was suspicious for malignancy (THY4) and the patient was referred for surgery. Histopathological findings revealed a papillary thyroid carcinoma. The molecular analysis did not show PAX8 or TSHR mutations in the thyroid tissue nor mutations of BRAF, H-RAS, N-RAS or K-RAS genes in the tumor. CONCLUSION: Though thus far studies on the association of thyroid hemiagenesis, Graves' disease and differentiated thyroid cancer are extremely rare, the possibility of the development of thyroid cancer must be taken into account in patients affected by thyroid hemiagenesis and the nodular variant of Graves' disease.
Asunto(s)
Carcinoma/patología , Enfermedad de Graves/diagnóstico , Disgenesias Tiroideas/patología , Neoplasias de la Tiroides/patología , Adulto , Carcinoma/epidemiología , Carcinoma Papilar , Comorbilidad , Enfermedad de Graves/epidemiología , Humanos , Masculino , Cáncer Papilar Tiroideo , Disgenesias Tiroideas/epidemiología , Neoplasias de la Tiroides/epidemiologíaRESUMEN
BACKGROUND: The morphological and biochemical phenotype of PAX8 mutation in patients with congenital hypothyroidism (CH) is variable. The contribution of mutations in PAX8 gene in children with CH and dysgenetic thyroid glands still remains a subject of interest for researchers. PATIENTS AND METHODS: Some 48 children (37 girls and 11 boys) with CH associated with thyroid ectopy (n=22), agenesis (n=10), hypoplasia (n=6), or thyroid dysgenesis of unknown cause (n=10) were enrolled. The study participants were born in south-eastern Poland in the years 1993-2012 and were selected for neonatal mass screening for CH. DNA was extracted from peripheral blood samples using Master Pure DNA Purification Kit (Epicentre Biotechnologies, Madison, WI, USA). The 12 exons of the PAX8 gene along with their exon-intron boundaries were amplified and sequenced by the Sanger method. Capillary electrophoresis was run on ABI 3500 (Applied Biosystems, Carlsbad, CA, USA). RESULTS: Novel heterozygous transition in exon 3 (c.68G>A) was detected in a 3-year-old girl with a thyroid hypoplasia. This substitution was not identified in the patient's parents (de novo event). Additionally, a novel genetic variant in 3'UTR region of exon 12 (c.*416C>T) occurred in a 3-year-old boy with ectopic thyroid tissue and concomitant congenital urogenital malformation. This heterozygous variant was also detected in other healthy family members. Thirteen well-described single nucleotide polymorphisms were revealed in the PAX8 gene. CONCLUSIONS: The study reports on the occurrence of two novel heterozygous substitutions in the PAX8 gene. Estimation of the contribution of the revealed c.68G>A variant to the etiology of CH in a girl with hypoplastic thyroid requires further functional analysis.
Asunto(s)
Hipotiroidismo Congénito/genética , Pruebas Genéticas/métodos , Mutación/genética , Factores de Transcripción Paired Box/genética , Disgenesias Tiroideas/genética , Glándula Tiroides/patología , Adulto , Niño , Preescolar , Estudios de Cohortes , Hipotiroidismo Congénito/epidemiología , Femenino , Estudios de Seguimiento , Humanos , Recién Nacido , Masculino , Persona de Mediana Edad , Factor de Transcripción PAX8 , Linaje , Fenotipo , Polonia/epidemiología , Pronóstico , Disgenesias Tiroideas/epidemiología , Glándula Tiroides/metabolismoRESUMEN
BACKGROUND: Levothyroxine (l-T4) is commonly employed to correct hormone deficiency in children with congenital hypothyroidism (CH) and in adult patients with iatrogenic hypothyroidism. OBJECTIVE: To compare the daily weight-based dosage of the replacement therapy with l-T4 in athyreotic adult patients affected by CH and adult patients with thyroid nodular or cancer diseases treated by total thyroidectomy. DESIGN AND METHODS: A total of 36 adult patients (27 females and nine males) aged 18-29 years were studied; 13 patients (age: 21.5±2.1, group CH) had athyreotic CH treated with l-T4 since the first days of life. The remaining 23 patients (age: 24±2.7, group AH) had hypothyroidism after total thyroidectomy (14 patients previously affected by nodular disease and nine by thyroid carcinoma with clinical and biochemical remission). Patient weight, serum free thyroid hormones, TSH, thyroglobulin (Tg), anti-Tg, and anti-thyroperoxidase antibodies were measured. Required l-T4 dosage was evaluated. At the time of the observations, all patients presented free thyroid hormones within the normal range and TSH between 0.8 and 2âµIU/ml. RESULTS: Patients had undetectable Tg and anti-thyroid antibodies. The daily weight-based dosage of the replacement therapy with l-T4 to reach euthyroidism in patients of group CH was significantly higher than that in those of group AH (2.16±0.36 vs 1.73±0.24âµg/kg, P<0.005). Patients of group CH treated with l-T4 had significantly higher serum TSH levels than patients of group AH (P=0.05) as well as higher FT4 concentrations. CONCLUSIONS: To correct hypothyroidism, patients of group CH required a daily l-T4 dose/kg higher than group AH patients, despite higher levels of TSH. The different requirement of replacement therapy between adult patients with congenital and those with surgical athyroidism could be explained by a lack of thyroid hormones since fetal life in CH, which could determine a different set point of the hypothalamus-pituitary-thyroid axis.
Asunto(s)
Hipotiroidismo Congénito/tratamiento farmacológico , Terapia de Reemplazo de Hormonas/métodos , Hipotiroidismo/tratamiento farmacológico , Disgenesias Tiroideas/tratamiento farmacológico , Síndrome de Resistencia a Hormonas Tiroideas/tratamiento farmacológico , Tiroxina/uso terapéutico , Adolescente , Adulto , Hipotiroidismo Congénito/sangre , Hipotiroidismo Congénito/epidemiología , Femenino , Terapia de Reemplazo de Hormonas/estadística & datos numéricos , Humanos , Sistema Hipotálamo-Hipofisario/patología , Hipotiroidismo/sangre , Hipotiroidismo/epidemiología , Masculino , Disgenesias Tiroideas/sangre , Disgenesias Tiroideas/epidemiología , Síndrome de Resistencia a Hormonas Tiroideas/sangre , Síndrome de Resistencia a Hormonas Tiroideas/epidemiología , Hormonas Tiroideas/sangre , Tiroidectomía , Tiroxina/administración & dosificación , Tiroxina/sangre , Adulto JovenRESUMEN
This record review of 82 children with Down Syndrome (DS) between April 2004 and March 2014 who had thyroid dysfunction, showed that majority (76, 92.6%) had subclinical hypothyroidism. Of the 60 patients who underwent radionuclide scan, 63.3% had a normal gland; the rest exhibited only impaired tracer uptake. Ultrasonograms done in 20 patients showed reduction of thyroid gland size in 3 (15%) patients only.
Asunto(s)
Síndrome de Down , Hipotiroidismo , Disgenesias Tiroideas , Adolescente , Niño , Preescolar , Síndrome de Down/complicaciones , Síndrome de Down/epidemiología , Femenino , Humanos , Hipotiroidismo/complicaciones , Hipotiroidismo/epidemiología , India/epidemiología , Lactante , Masculino , Disgenesias Tiroideas/complicaciones , Disgenesias Tiroideas/epidemiologíaRESUMEN
CONTEXT: Congenital hypothyroidism, the most frequent endocrine congenital disease, can occur either based on a thyroid hormone biosynthesis defect or can predominantly be due to thyroid dysgenesis. However, a genetic cause could so far only be identified in less than 10% of patients with a thyroid dysgenesis. OBJECTIVES: Exome sequencing was used for the first time to find additional genetic defects in thyroid dysgenesis. PATIENTS AND METHODS: In a consanguineous family with thyroid dysgenesis, exome sequencing was applied, and findings were further validated by Sanger sequencing in a cohort of 94 patients with thyroid dysgenesis. RESULTS: By exome sequencing we identified a homozygous missense mutation (p.Leu597Ser) in the SLC26A4 gene of a patient with hypoplastic thyroid tissue, who was otherwise healthy. In the cohort of patients with thyroid dysgenesis, we observed a second case with a homozygous missense mutation (p.Gln413Arg) in the SLC26A4 gene, who was additionally affected by severe hearing problems. Both mutations were previously described as loss-of-function mutations in patients with Pendred syndrome and nonsyndromic enlarged vestibular aqueduct. CONCLUSION: We unexpectedly identified SLC26A4 mutations that were hitherto diagnosed in thyroid dyshormonogenesis patients, now for the first time in patients with structural thyroid defects. This result resembles the historic description of thyroid atrophy in patients with the so-called myxedematous form of cretinism after severe iodine deficiency. Most likely the thyroid defect of the two homozygous SLC26A4 gene mutation carriers represents a kind of secondary thyroid atrophy, rather than a primary defect of thyroid development in the sense of thyroid agenesis. Our study extends the variable clinical spectrum of patients with SLC26A4 mutations and points out the necessity to analyze the SLC26A4 gene in patients with apparent thyroid dysgenesis in addition to the known candidate genes TSHR, PAX8, NKX2.1, NKX2.5, and FOXE1.
Asunto(s)
Hipotiroidismo Congénito/genética , Proteínas de Transporte de Membrana/genética , Disgenesias Tiroideas/genética , Adolescente , Estudios de Casos y Controles , Estudios de Cohortes , Hipotiroidismo Congénito/complicaciones , Hipotiroidismo Congénito/epidemiología , Análisis Mutacional de ADN , Femenino , Estudios de Asociación Genética , Humanos , Masculino , Mutación , Linaje , Transportadores de Sulfato , Disgenesias Tiroideas/complicaciones , Disgenesias Tiroideas/epidemiología , TurquíaRESUMEN
CONTEXT: Over the years lower TSH cutoffs have been adopted in some screening programs for congenital hypothyroidism (CH) worldwide. This has resulted in a progressive increase in detecting additional mild forms of the disease, essentially with normally located and shaped thyroid. However, the question of whether such additional mild CH cases can benefit from detection by newborn screening and early thyroid hormone treatment is still open. OBJECTIVE: The aim of this study was to estimate the frequency of cases with mild increase of TSH at screening in the Italian population of babies with permanent CH and to characterize these babies in terms of diagnosis classification and neonatal features. METHODS: Data recorded in the Italian National Registry of infants with CH were analyzed. RESULTS: Between 2000 and 2006, 17 of the 25 Italian screening centers adopted a TSH cutoff at screening of <15.0 µU/mL. It was found that 21.6% of babies with permanent CH had TSH at screening of 15.0 µU/mL or less, whereas this percentage was 54% in infants with transient hypothyroidism. Among the babies with permanent CH and mild increase of TSH at screening (≤15 µU/mL), 19.6% had thyroid dysgenesis with serum TSH levels at confirmation of the diagnosis ranging from 9.9 to 708 µU/mL. These babies would have been missed at screening if the cutoff had been higher. CONCLUSIONS: Lowering TSH cutoff in our country has enabled us to detect additional cases of permanent CH, a number of which had defects of thyroid development and severe hypothyroidism at confirmation of the diagnosis.